The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, etc. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results.
Anti-angiogenesis Drug Discovery and Development provides an excellent compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews have been contributed by leading practitioners in drug discovery science and highlight the major developments in this exciting field in the last two decades. The feast of these reader-friendly reviews on topics of great scientific importance – many of which are considered significant medical breakthroughs, makes this book excellent reading both for the novice as well as for expert medicinal chemists and clinicians.
This volume brings together 5 reviews on these topics:
-Beta-blockers for treating premature retinopathy
-Anti-angiogenic activity of disintegrin-based, synthetic cyclic KTS peptides
-Anti-angiogenic therapy of lung cancer
-Oral anti-angiogenic therapy for NSCLC
-Angiogenesis in hepatocellular carcinoma